REG - BkofA Merrill Lynch Horizon Therapeutics - 20230901_HORIZON THERAPEUTICS PLC_38.5 (b)_BOFAS

AmgenAnnouncement

04/09/2023 12:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230904:nRSD2910La&default-theme=true

RNS Number : 2910L  Bank of America Merrill Lynch  04 September 2023

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT

RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY

STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 1.  KEY INFORMATION

 Name of exempt principal trader             BofA Securities, Inc.
 Company dealt in                            HORIZON THERAPEUTICS PLC
 Class of relevant security to which the     Common - IE00BQPVQZ61

dealings being disclosed relate(Note 1)
 Date of dealing                             01/09/2023

BofA Securities, Inc.

 Company dealt in

HORIZON THERAPEUTICS PLC

 Class of relevant security to which the

dealings being disclosed relate(Note 1)

Common - IE00BQPVQZ61

 Date of dealing

01/09/2023

 

 2.  INTERESTS AND SHORT POSITIONS

 (a)  Interests and short positions (following dealing) in the class of relevant
      security

dealt in (Note 2)

 Class of relevant security: Common             IE00BQPVQZ61
                                                Long             Short
                                                Number   %       Number   %
 (1)  Relevant securities                       219,747  0.096%  110,353  0.048%
 (2)  Derivatives (other than options):         167,406  0.073%  60,931   0.027%
 (3)  Options and agreements to purchase/sell:  50,000   0.022%  19,500   0.009%
 Total                                          437,153  0.191%  190,784  0.084%

219,747

0.096%

110,353

0.048%

 (2)  Derivatives (other than options):

167,406

0.073%

60,931

0.027%

 (3)  Options and agreements to purchase/sell:

50,000

0.022%

19,500

0.009%

Total

437,153

0.191%

190,784

0.084%

 

 (b)  Interests and short positions in relevant securities of the company, other
      than the

class dealt in (Note 2)

 Class of relevant security:
                                                Long         Short
                                                Number  %    Number  %
 (1)  Relevant securities                       0       0%   0       0%
 (2)  Derivatives (other than options):         0       0%   0       0%
 (3)  Options and agreements to purchase/sell:  0       0%   0       0%
 Total                                          0       0%   0       0%

0

0%

0

0%

 (2)  Derivatives (other than options):

0

0%

0

0%

 (3)  Options and agreements to purchase/sell:

0

0%

0

0%

Total

0

0%

0

0%

 3.  DEALINGS (Note 3)

 (a)  Purchases and sales

 Purchase/sale  Number of relevant securities  Price per unit (Note 4)
 Purchase       200                            115.33 USD
 Purchase       3,642                          115.3 USD
 Purchase       100                            115.29 USD
 Purchase       501                            115.27 USD
 Purchase       1,500                          115.28 USD
 Purchase       101                            115.32 USD
 Purchase       2,289                          115.34 USD
 Purchase       130                            115.335 USD
 Purchase       100                            115.35 USD
 Purchase       806                            115.31 USD
 Purchase       1,300                          115.255 USD
 Purchase       901                            115.26 USD
 Purchase       8,768                          115.25 USD
 Purchase       2,462                          115.245 USD
 Purchase       3,445                          115.24 USD
 Purchase       900                            115.215 USD
 Purchase       500                            115.22 USD
 Purchase       100                            115.235 USD
 Purchase       636                            115.85 USD
 Purchase       30,514                         115.9 USD
 Purchase       4,486                          115.89 USD
 Purchase       1,013                          115.3 USD
 Purchase       126,034                        115.6 USD
 Purchase       25,000                         115.8 USD

 

 Purchase/sale  Number of relevant securities  Price per unit (Note 4)
 Sale           8,904                          115.33 USD
 Sale           354                            115.3 USD
 Sale           17,344                         115.57 USD
 Sale           2,700                          115.515 USD
 Sale           4,139                          115.53 USD
 Sale           1,400                          115.54 USD
 Sale           35,182                         115.55 USD
 Sale           440                            115.47 USD
 Sale           400                            115.51 USD
 Sale           7,900                          115.52 USD
 Sale           450                            115.525 USD
 Sale           2,600                          115.535 USD
 Sale           17,400                         115.555 USD
 Sale           16,752                         115.56 USD
 Sale           21,200                         115.565 USD
 Sale           1,195                          115.575 USD
 Sale           25,657                         115.58 USD
 Sale           100                            115.585 USD
 Sale           300                            115.558 USD
 Sale           1,401                          115.6 USD
 Sale           39,503                         115.59 USD
 Sale           5,420                          115.595 USD
 Sale           1                              115.64 USD
 Sale           23,308                         115.68 USD
 Sale           27,748                         115.75 USD
 Sale           8,259                          115.7 USD
 Sale           25,000                         115.593 USD
 Sale           9,944                          115.69 USD
 Sale           7,781                          115.71 USD
 Sale           700                            115.695 USD
 Sale           396                            115.95 USD

 

 (b)  Derivatives transactions (other than options transactions)

 Product name,  Nature of transaction       Number of relevant securities  Price per unit

e.g. CFD
(Note 5)                   (Note 6)
(Note 4)
 Swaps          Increasing a Long Position  317                            115.302 USD
 Swaps          Closing a Short Position    8,904                          115.328 USD
 Swaps          Reducing a Long Position    2,742                          115.3 USD

 

 (c)  Options transactions in respect of existing relevant securities

 (i)  Writing, selling, purchasing or varying

 Product name, e.g. call option  Writing, selling, purchasing, varying etc.  Number of securities to which the option relates (Note 7)  Exercise price  Type, e.g. American, European etc  Expiry date  Option money paid/ received per unit (Note 4)
 N/A                             N/A                                         N/A                                                        N/A             N/A                                N/A          N/A

 

 (ii)  Exercising

 Product name,      Number of securities  Exercise price per

e.g. call option
unit (Note 4)
 N/A                N/A                   N/A

 

 (d)  Other dealings (including transactions in respect of new securities) (Note 3)

 Nature or transaction  Details  Price per unit
 (Note 7)
(if applicable) (Note 4)
 N/A                    N/A      N/A

 

 4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 Full details of any agreement, arrangement or understanding between the person

disclosing and any other person relating to the voting rights of any relevant

securities under any option referred to on this form or relating to the voting
 rights

or future acquisition or disposal of any relevant securities to which any
 derivative

referred to on this form is referenced. If none, this should be stated.
 None

 

 Is a Supplemental Form 38.5(b) attached? (Note 8)  No

 

 Date of disclosure                            04/09/2023
 Contact name                                  Frank Lui
 Telephone number                              +44207 996 6418
 Name of offeree/offeror with which connected  AMGEN INC
 Nature of connection (Note 9)                 Advisor to - AMGEN INC

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ITPGZGGLGDGGFZM